BICYCLE THERAPEUTICS PLC - 8-K Filing

Bicycle Therapeutics reported Q2 2026 financial results and business updates including clinical data, cash balance of $510.1M as of June 30, 2026, and a net loss of $50.3M. (Items: 2.02 Results of Operations and Financial Condition On July 30, 2026, Bicycle Therapeutics plc issued a press release announcing financial results, 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No)

SEC EDGAR ·

Tickers: $BCYC

Read the full article at SEC EDGAR

More Regulatory news